XML 55 R24.htm IDEA: XBRL DOCUMENT v3.19.3
Revenue from Contracts with Customers (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]    
Schedule of Revenues by Type of Service

The Company provides diagnostic test products, laboratory services to hospitals, clinical laboratories and other healthcare provider customers, and enters into collaboration agreements with government agencies and healthcare providers. The revenues by type of service consist of the following:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Product sales

 

$

504,293

 

 

$

632,525

 

 

$

1,024,470

 

 

$

1,266,021

 

Laboratory services

 

 

5,250

 

 

 

1,100

 

 

 

5,250

 

 

 

9,790

 

Collaboration revenue

 

 

500,000

 

 

 

155,276

 

 

 

1,000,000

 

 

 

359,316

 

Total revenue

 

$

1,009,543

 

 

$

788,901

 

 

$

2,029,720

 

 

$

1,635,127

 

The Company provides diagnostic test products, laboratory services to hospitals, clinical laboratories and other healthcare provider customers, and enters into collaboration agreements with government agencies and healthcare providers. The revenues by type of service consist of the following:

 

 

 

December 31,

 

 

 

2018

 

 

2017

 

Product sales

 

$

2,395,626

 

 

$

2,771,869

 

Laboratory services

 

 

34,665

 

 

 

41,960

 

Collaboration revenue

 

 

516,016

 

 

 

397,178

 

Total revenue

 

$

2,946,307

 

 

$

3,211,007

 

Summary of Changes in Deferred Revenue

Changes in deferred revenue for the period were as follows:

 

Balance at December 31, 2018

 

 

 

 

 

 

 

$

15,824

 

Revenue recognized in the current period from the amounts in the beginning balance

 

 

 

 

 

 

 

 

(5,831

)

New deferrals, net of amounts recognized in the current period

 

 

 

 

 

 

 

 

 

Balance at June 30, 2019

 

 

 

 

 

 

 

$

9,993

 

Changes in deferred revenue for the period were as follows:

 

Balance at December 31, 2017

 

 

 

$

24,442

 

Revenue recognized in the current period from the amounts in the beginning balance

 

 

 

 

(14,450

)

New deferrals, net of amounts recognized in the current period

 

 

 

 

5,832

 

Balance at December 31, 2018

 

 

 

$

15,824